Bionicon
1-800-SKIRMISH
Effects of Zelanine in
the absence
of a stabilizing agent
Zelanine
has been proven an effective method for accelerating growth in both
humans and animals when combined with its genorhythmic partner drug,
anti regenerative haloxide. This study explored the possible
benefits of use zelanine not in combination with any other drug.
Without the inhibiting properties of the stabilizing agent, significant growth was achieved in less time. This could have profound effects on both the farming industry and military applications. The ability to grow larger livestock and increase the fighting strength of the average human recruit will ensure the profitabiliity of zelanine for decades to come. These results were welcomed by our shareholders.
Also, Bionicon will be pursuing over the counter sales of zelanine combined with anti regenerative haloxide. Greater profits will be achieved if we can elminate the need for anti regenerative haloxide in the forumla, as it is much more expensive to produce than zelanine alone. Also, consumers would prefer the more rapid results of pure zelanine if we are able to bring it to market.
The results of this study were inconclusive. Bionicon scientists have determined that increasing the standard dose of zelanine in combination with anti regenerative haloxide to 10 mg instead of 5 mg will help speed results without increasing production costs.
Test subjects are currently undergoing continuing observation to discern any long-term effects of treatment. Bionicon is committed to following the highest standards for animal testing and human experimentation and the strictest protocols for disposal of biohazardous waste.
Without the inhibiting properties of the stabilizing agent, significant growth was achieved in less time. This could have profound effects on both the farming industry and military applications. The ability to grow larger livestock and increase the fighting strength of the average human recruit will ensure the profitabiliity of zelanine for decades to come. These results were welcomed by our shareholders.
Also, Bionicon will be pursuing over the counter sales of zelanine combined with anti regenerative haloxide. Greater profits will be achieved if we can elminate the need for anti regenerative haloxide in the forumla, as it is much more expensive to produce than zelanine alone. Also, consumers would prefer the more rapid results of pure zelanine if we are able to bring it to market.
The results of this study were inconclusive. Bionicon scientists have determined that increasing the standard dose of zelanine in combination with anti regenerative haloxide to 10 mg instead of 5 mg will help speed results without increasing production costs.
Test subjects are currently undergoing continuing observation to discern any long-term effects of treatment. Bionicon is committed to following the highest standards for animal testing and human experimentation and the strictest protocols for disposal of biohazardous waste.